The primary focus of our products is on viscoelastic products in the treatment of osteoarthritis. By studying and examining the hyaluronic acid molecule, we have produced ready-to-Administer sterile injection products under the Synogel and Viscor brands and marketed them in the Iranian pharmaceutical market.
At Nitka, we strive to identify and produce new and widely used products for different needs of patients. Our team is expanding and advancing clinical trials and entering new areas of treatment.
Our R&D program includes the expansion of clinical studies on new products in the field of orthopedic products and other therapeutic fields.
Viscor® contains high molecular weight sterile hyaluronic acid, which due to its high weight has a greater effect compared with products containing low molecular weight hyaluronic acid and is stored longer in the inter-joint space therefore considerably decreases the pain and inflammation in the patient for a longer period of time. One of the advantages of this product is being single injection, which is a special feature that reduces the risk of infection and the number of times patients needs to be visited.
Hyaluronic acid is a complex carbohydrate that is one of the most important constituents of joint fluid. Hyaluronic acid in the joint has the property of viscoelasticity that causes the joints to lubricate. This substance is produced in the joints from type B synoviocytes. Hyaluronic acid deficiency causes complications such as osteoarthritis.
Osteoarthritis involves the breakdown of articular cartilage and eventually the involvement of subcutaneous bone, which causes inflammation of the surrounding tissues and reduced mobility of the joints. This complication may affect any of the joints. The most common joints involved are the knee, arm, pelvis and spine. Preventing osteoarthritis, especially in younger patients, is always the first step in delaying surgery.
Pre-filled syringes of synogel® contain high molecular weight sterile hyaluronic acid. Intra-articular injection of hyaluronic acid is an approved treatment to prevent the progression of osteoarthritis, which is performed by a specialist. Osteoarthritis involves the breakdown of articular cartilage and eventually the involvement of subcutaneous bone, which causes inflammation of the surrounding tissues. This complication may affect any of the joints. The most common joints involved are knee, arm, pelvis and spine. One of the benefits of Synogel® is its long-term effect. With this property, Synogel® can increase the quality of life of patients for one year. Synogel ® injection is usually between 3 and 5 injections per visit, depending on the severity of the injury.